Dmitri V. Lissin
Direttore Tecnico/Scientifico/R&S presso SCILEX HOLDING COMPANY
Posizioni attive di Dmitri V. Lissin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCILEX HOLDING COMPANY | Direttore Tecnico/Scientifico/R&S | - | - |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Direttore/Membro del Consiglio | 10/07/2015 | - |
| Direttore Tecnico/Scientifico/R&S | 01/07/2015 | - | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Direttore Tecnico/Scientifico/R&S | 01/03/2019 | - |
Storia della carriera di Dmitri V. Lissin
Precedenti posizioni note di Dmitri V. Lissin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XENOPORT, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2011 | 01/08/2015 |
Formazione di Dmitri V. Lissin
| Russian National Research Medical University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Aziende private | 3 |
|---|---|
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Dmitri V. Lissin
- Esperienza
